All posts by medical

Cambridge-based Sano Genetics gets a capital injection of 2.5M to offer free at-home DNA testing kits for those affected by Long COVID – UKTN (UK…

Sano Genetics, a Cambridge-based startup with an aim to support personalised medicine research by increasing participation in clinical trials and guiding patients all through the process has recently grabbed 2.5M seed funding from a slew of investors.

The financing round was led by Episode1 Ventures along with participation from Cambridge Enterprise, Seedcamp, January Venture and a slew of angel investors from UK, Europe and US. Previously, Sano Genetics raised 500K pre-seed funding in 2018.

The latest funding round includes a grant from Innovate UK, which will cover the cost of free at-home DNA testing kits for 3,000 people affected by Long Covid. Also, the investment will be used for the continuous development of its private-by-design tech platform, which gives full control and transparency for users regarding how and where their personal data is used by researchers.

Chief operating officer of Sano Genetics, Charlotte Guzzo, explained: This tranche of funding will help us further develop the end-to-end experience for the many people keen to contribute to personalised medical research, including clinical trials of potentially life-changing medicines and, in doing so, improve the outlook for people living with chronic and often debilitating conditions.

Besides the funding, Sano Genetics partnered with Genomics England to develop software that will be used for national-scale precision medicine initiatives. It will improve the participants experience in research. This software will add a vital layer of information reported directly by participants including daily symptom tracking or via wearable devices monitoring activity or sleep.

Sano Genetics was founded in 2017 by Charlotte Guzzo, Patrick Short and William Jones while pursuing genomics at Cambridge University. They observed, first hand, the high failure rate of clinical trials and the poor experience for those taking part. The startups digital platform and at-home genetic testing capabilities are already empowering greater participation in crucial research into multiple sclerosis, ankylosing spondylitis, NAFLD, and ulcerative colitis. Also, it plans for a research programme for Parkinsons disease for late this year.

Original post:
Cambridge-based Sano Genetics gets a capital injection of 2.5M to offer free at-home DNA testing kits for those affected by Long COVID - UKTN (UK...

‘Sticking with what we have and selecting superior genetics seen as the way forward’ – Agriland

Sticking with what we have and selecting for superior genetics rather than importing genetics from New Zealand is seen as the way forward for Irish sheep farmers, according to Nicola Featherstone.

Nicola was speaking at the first of two virtual Teagasc Sheep Conferences which were held yesterday evening (Tuesday, January 26).

Teagasc Walsh Scholar Nicola gave an update on the INZAC trial in Teagasc Athenry, Co. Galway, which compares 1-star and 5-star Irish ewes with elite New Zealand ewes.

One question put to Nicola during yesterdays session was how relevant did she think New Zealand sheep are in an Irish context and if they are far superior to what we have here in Ireland?

She explained: During my time in New Zealand, along with visiting a number of farms, I also collaborated with a consultancy company and over there we generated a model and that model looked at all different scenarios that we could put into practice here in Ireland.

For example, whether or not we would look at importing New Zealand genetics or should we stick with what we have here in Ireland or maybe a mixture of both.

From looking at the results, it showed that the benefit, in terms of genetics and economics, would be greater for the Irish industry if we stuck with what we have rather than importing New Zealand genetics, as long as we source our genetics from more progressive breeders.

So, essentially, it means that we need commercial farmers to drive demand towards sourcing animals of superior genetics.

If we stick with the system we have which identifies the elite animals, in terms of being 5-stars, then this is the best way forward for Irish sheep farmers.

RELATED STORIES

The rest is here:
'Sticking with what we have and selecting superior genetics seen as the way forward' - Agriland

Partners in Crime: Genetic Collaborator May Influence Severity of the Rare Disease, NGLY1 – Newswise

Newswise In 2012, four-year-old Bertrand Might became the first-ever patient diagnosed with a rare genetic disorder called N-glycanase (NGLY1) deficiency. The discovery of this condition and Bertrands diagnosis allowed doctors to look for other children with the same genetic defect. Since then, more than 60 additional patients have been found. The disease affects every system of the body and is characterized by low muscle tone, seizures, developmental delays, and an inability to produce tears.

Sadly, Bertrand passed away in October at the age of 12. Although his life was cut short, his legacy will benefit children around the world. Through their website, NGLY1.org, Bertrands parents collect and share a wealth of research and family stories to help educate and inform the community. As more patients have been identified, its become apparent that even though the same gene is deactivated in all of them, their symptoms and severity of disease vary widely.

Geneticist Clement Chow, Ph.D., assistant professor in the Department of Human Genetics at University of Utah Health, studies NGLY1 deficiency in the fruit fly, Drosophila melanogaster. To understand how the disease symptoms can vary so much, he and his colleagues are hunting for other genes that interact with NGLY1. In a paper published in eLife, Chow reports that his lab has found that one of these interacting genes moderates disease severity. The gene, called ncc69, has a human counterpart called NKCC1. Their experiments showed that NGLY1 chemically modifies NKCC1. Studying this interaction could help illuminate how NGLY1 deficiency affects the body.

Common diseases, such as heart disease or cancer, arise from a combination of many genetic and environmental causes, while rare diseases are more likely caused by a single gene. But every single-gene disease occurs against the individual patients unique genetic backdrop, a patchwork of different genetic variants inherited from both parents. Children with NGLY1 deficiency start experiencing serious symptoms early in life, suggesting that environmental differences, such as diet, arent a key factor. More likely, differences in their other genes are influencing the clinical course of the disease.

To search for genes that work together with NGLY1, the researchers needed to use flies with varied genetic backgrounds. Laboratory flies, however, are inbred to be genetically identical. To approximate the natural genetic diversity found in humans, Chow turned to a resource called the Drosophila Genetic Reference Panel. Its a collection of 200 different fruit fly lines, all bred from the same original populationbut each one is just a bit different from the others.

Its like if you sampled 200 Northern Europeans, Chow says. Theyd share lots of genetic variants, but lots of differences as well.

In each strain of flies, Chow and his research team swapped in a non-working copy of the NGLY1 gene, then looked for differences in survival. Strikingly, the flies genetic background heavily influenced how long the young flies could survive without NGLY1.

These flies all carry the same disease mutation thats supposed to cause the same disease, Chow says. Yet here were seeing that, in some genetic backgrounds, they cant live at all with NGLY1 deficiency. And in some genetic backgrounds, all the flies survived to adulthood.

The researchers analyzed the genes that varied among the flies that survived and those that died, coming up with a list of candidate genes that could be playing a role. They began studying one of these candidates, NKCC1, and soon switched from flies to mice.

When we hit a wall in what we could do with flies, we decided to turn to the mouse model to try to fully characterize what NKCC1 and NGLY1 are doing to interact with each other, Chow says.

In cells from mice, the researchers discovered that the NKCC1 protein assumes its correct shape through glycosylation, a chemical process that tacks sugar molecules onto the protein. NGLY1 acts to remove these sugar molecules from specific targets.

In the absence of NGLY1, Chow found, NKCC1 was overloaded with extra sugars, reducing activity in the cell by 50%. Without NGLY1, NKCC1 cant do its job properly, which is to move fluids and ions out of the cell.

While application to human disease is still a long way off, the role of NKCC1 makes sense in terms of the symptoms seen in NGLY1 patients. One of the hallmark features of NGLY1 deficiency is the inability to make tears, sweat, and saliva. It turns out that patients who lack NKCC1 also have this symptom. NKCC1 is active in salivary glands, sweat glands, and tear ducts, which supports the idea that the molecule plays a role in causing the symptoms.

This was all discovered through a genetic screen in Drosophila, Chow says. This really speaks to the power of using simpler model organisms, especially for rare diseases, where you want to get results faster.

-Written by Caroline Seydel

# # #

In addition to U of U Health scientists, contributors include researchers from the University of Pittsburgh, The Jackson Laboratory and the Veterans Affairs Salt Lake City Health System.

The study published as A Drosophila screen identifies NKCC1 as a modifier of NGLY1 deficiency and was supported by the National Institutes of Health, Might Family, and the Glenn Foundation for Medical Research.

View original post here:
Partners in Crime: Genetic Collaborator May Influence Severity of the Rare Disease, NGLY1 - Newswise

Human Fertilisation and Embryology Authority annual report and accounts: 2019 to 2020 – GOV.UK

Help us improve GOV.UK

To help us improve GOV.UK, wed like to know more about your visit today. Well send you a link to a feedback form. It will take only 2 minutes to fill in. Dont worry we wont send you spam or share your email address with anyone.

Email address

Read the rest here:
Human Fertilisation and Embryology Authority annual report and accounts: 2019 to 2020 - GOV.UK

The Promise and Peril of the Bio-Revolution by Matthias Evers & Michael Chui – Project Syndicate

Many of todays biological innovations are complex, and we need to understand them fully to gauge their impact on our lives and societies. Only by working together can governments, scientists, businesses, and the public unleash the power of biology for good while effectively managing the risks.

HAMBURG Last November, the world cheered the news that three gene-based COVID-19 vaccines one developed by German biotech company BioNTech in collaboration with Pfizer, another by US-based biotech firm Moderna, and a third by the University of Oxford and AstraZeneca had proved effective in clinical trials. But in October, researchers revealed that off-target effects of the CRISPR-Cas9 gene-editing tool used to repair a blindness-causing gene in the early stages of human embryo development often eliminated an entire chromosome or a large part of it.

The two announcements, coming just a month apart, illustrate the promise and peril of biological engineering.

As a recent report from the McKinsey Global Institute (MGI) makes clear, current breakthroughs in biological science and advanced data analytics could help us solve major human challenges, from reducing climate risk and strengthening food security to fighting pandemics. But realizing the revolutions potentially huge benefits will require us to think carefully about how to mitigate the potentially severe risks.

The scope of todays bio-innovation wave is large. Some 60% of physical inputs to the world economy are either already biological, or could be produced using biological processes in the future. Nylon, for example, can already be made using genetically-engineered yeast, rather than petrochemicals. Many such bioroutes to production potentially will use less energy and water, and generate fewer greenhouse-gas (GHG) emissions. Just 400 biological applications currently in the pipeline could reduce annual average GHG emissions by as much as 9% by 2050.

CRISPR-Cas9 stands out as an increasingly accessible technology for manipulating genetic material, and is complemented by rapid and low-cost genetic sequencing and advances in data analytics that enable scientists to understand biological processes better. Our deepening knowledge of biology genes, microbiomes, and neural signals is making it increasingly possible to engineer life.

But modifying biology is inherently risky. With CRISPR kits now available for sale on the internet, anyone with some degree of biological knowledge could potentially create and release a new living entity, including harmful bacteria or viruses.

Enjoy unlimited access to the ideas and opinions of the world's leading thinkers, including weekly long reads, book reviews, and interviews; The Year Ahead annual print magazine; the complete PS archive; and more All for less than $9 a month.

Subscribe Now

Biological organisms are self-replicating, self-sustaining, and interrelated. Moreover, as the rapid global spread of COVID-19 has demonstrated, they do not respect political borders. For example, so-called gene drives applied to infectious-disease vectors (such as Anopheles mosquitoes in the case of malaria) could save many lives, but we may not be able to control them. The next generation of genetically-edited mosquitoes in one field experiment in Brazil were supposed to die, but are still breeding five years later.

Another concern is data privacy. The rapid spread of digital technologies has triggered an intense debate about technology companies use of personal data, such as that relating to purchasing habits and social-media activity. But access to biological data from our bodies and brains represents another level of intimate knowledge.

Moreover, the bio-revolution could entrench inequality, at least while applications such as breakthrough therapies, performance enhancements, and reproductive selection remain expensive and thus accessible only to the well-off. MGI estimates that about 70% of the reduction in disease in the next 10-20 years could be in high-income countries, despite the fact that they collectively account for only around 30% of the global disease burden.

Thus, unless managed carefully, the risks of some new biological applications may outweigh the potential benefits. Scientists cannot pursue innovation in a vacuum: societys concerns matter, and innovators must exercise consistent and effective oversight. Fortunately, they have a track record of doing so.

Back in 1975, for example, prominent scientists, lawyers, and medical professionals gathered at the Asilomar Conference in California to draw up voluntary guidelines to ensure the safety of recombinant DNA technology. More recently, the American biochemist Jennifer Doudna, who, together with French microbiologist Emmanuelle Charpentier, was awarded the 2020 Nobel Prize in Chemistry for inventing CRISPR, responded to the tools use to gene-edit twin human embryos by calling for stricter regulation of the technology.

Governments that regulate bio-innovations and the businesses that develop and use them need to be part of the sustained conversation on risk. In fact, we estimate that as much as 70% of the bio-revolutions potential impact will be in uses that fall under existing regulatory regimes.

Regulation today is uneven. For example, as of late 2019, the American Society for Reproductive Medicine largely was leaving it up to clinics and parents to decide what genetic testing and diagnosis is permissible in identifying defects within embryos before they are implanted. But the United Kingdoms Human Fertilisation & Embryology Authority regulates the procedure tightly, permitting its use only for medical purposes and, even then, only for certain disorders.

Ideally, citizens also need to be involved in the debate, because their level of comfort with how science is applied influences regulators. In the UK, for example, the independent Nuffield Council on Bioethics was established in 1991 to advise policymakers and stimulate public debate on bioethics.

Many of todays biological innovations are complex, and we need to understand them fully to gauge their impact on our lives and societies. Only by working together can governments, scientists, businesses, and the public unleash the power of biology for good while effectively managing the risks.

Read the original:
The Promise and Peril of the Bio-Revolution by Matthias Evers & Michael Chui - Project Syndicate

Study of Early Postoperative Doppler Changes Post Living Donor Liver T | IJGM – Dove Medical Press

Ahmed Salman,1 Amany Sholkamy,1 Mohamed Salman,2 Mahmoud Omar,1 Amr Saadawy,3 Ahmed Abdulsamad,4 Mohamed Tourky,5 Mohamed D Sarhan,2 Hossam El-Din Shaaban,6 Nesrin Abd Allah,7 Mohamed Shawkat8

1Internal Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt; 2General Surgery Department, Faculty of Medicine, Cairo University, Cairo, Egypt; 3Radiology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; 4Surgical Oncology, Alzahra Cancer Center, Dubai, United Arab Emirates; 5General Surgery Department, Omm Elmisrien General Hospital, Cairo, Egypt; 6Gastroenterology Department, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt; 7Anatomy and Embryology Department, Faculty of Medicine, Menoufia University, Shebin El-Kom, Menoufia, Egypt; 8Internal Medicine Department, Faculty of Medicine, Minia University, Minia, Egypt

Correspondence: Ahmed Salman Tel + 201000468664Email awea844@gmail.com

Background: Adult-to-adult living donor liver transplantation (LDLT) has been a common practice because of the deficiency of deceased donor liver transplants. Liver hemodynamics differ substantially between cases with end-stage liver disease undergoing LT because of various degrees of hepatic affection, nature of implicated causative factors, and pathogenesis of the hepatic disorder. The present retrospective study primarily aimed to study the early postoperative doppler changes after adult to adult LDLT. The secondary aim was to assess these hemodynamics impact on early in-hospital deaths and small for size syndrome (SFSS) development.Methods: This retrospective work was done on 123 adult cases with end-stage liver disease for whom adult LDLT was performed after exclusion of pediatric patients and those with vascular complications.Results: Postoperative (PO) mean portal vein velocity (PVV), hepatic artery (HA) peak systolic velocity (PSV), and HA resistivity index (RI) declined gradually but significantly post adult LDLT. Phasicity of hepatic veins changes towards the triphasic waveform gradually in the early PO period. There is a notable negative relationship between PO mean PVV with PO mean HA PSV. Higher PO HA RI affected PO mortality, while higher PO PVV and lower HA PSV increased the incidence of SFSS.Conclusion: Early postoperative Doppler changes post-LDLT (PO PVV, HA RI, and HA PSV) can affect both mortality and SFSS development.

Keywords: postoperative doppler, LDLT, small-for-size syndrome, mortality

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Read the original post:
Study of Early Postoperative Doppler Changes Post Living Donor Liver T | IJGM - Dove Medical Press

Embryo freezing is revolutionary for those who can’t conceive – Palatinate

By Caitlin Painter

In October 1992, an embryo was frozen by an anonymous couple. It remained frozen for over 27 years until thawed by the National Embryo Donation Centre (NEDC) in Knoxville, Tennessee, and transferred into the uterus of a woman unable to conceive naturally. Born in October 2020, Molly Gibson is believed to hold the record for the longest frozen embryo to result in a birth.

The embryo remained frozen for over 27 years until thawed

Embryo freezing has been practised since the early 1980s, but it was initially unclear how long they could be frozen. The typical duration is 10 years, but as proven by Molly Gibson, decadesold embryos can still lead to successful births. The majority of stored embryos that can be adopted have been donated by individuals who have undergone in vitro fertilisation (IVF), after a successful implantation.

IVF is a popular technique available to help people with fertility problems become pregnant. After hormone treatments, a womans eggs are collected and fertilised, and the highest quality embryos can then be implanted, with unused ones typically frozen for further IVF attempts.

As proven by Molly Gibson, decades-old embryos can lead to successful births

A standard freezing process involves replacing water in the cells with a cryoprotectant, and then freezing the embryo extremely quickly to temperatures around -200C (known as vitrification) to prevent ice crystals forming. However, IVF creates a surplus of embryos, and the parent(s) have the decision of what becomes of them. Many choose to discard them. Some are donated for research and training purposes, whilst others are stored for embryo adoptions.

Dr Fiona MacCallum of the University of Warwick believes that the term embryo adoption is misleading, arguing that viewing embryo donations akin to adoptions could shift the public perspective of embryos more towards personhood status.

Dr Fiona MacCallum believes the term embryo adoption is misleading

This could have a great impact on stem cell research, where embryos are frequently used and subsequently destroyed. With this attitude, there is the possibility that embryos could undergo pre-implantation genetic screening. This is currently applied to check an embryo for specific genetic conditions, but could be misused to determine the future characteristics of the child.

Under the Human Fertilisation and Embryology Act of 2008, it is illegal in the UK to select the sex of embryos for non-medical purposes, whether during IVF with a persons own embryos or adopting them. It is common, however, for prospective parents to choose donated embryos of the same ethnicity as themselves, as well as from donor parents they share features with. It was only after they had chosen their desired embryos that Molly Gibsons parents discovered when they had been frozen.

Embryo freezing is the most effective way to preserve fertility, more than freezing eggs

For parents who are unable to conceive, embryo donations provide the opportunity of experiencing pregnancy and birth, with a 75% success rate of donated embryos surviving thawing and transferring. Of these embryos, 25 to 30% are implanted successfully, according to the NEDC.

Embryo freezing is also used by women about to undergo cancer treatments that may result in infertility, but who want a child afterwards. The UKs Human Fertilisation and Embryonic Authority evidences that embryo freezing is the most effective way for women to preserve fertility, more so than freezing eggs. Hence some women choose to freeze their fertilised eggs to increase their chances of a successful pregnancy later in life.

Older mothers are at a much greater risk of complications during pregnancy

Women may choose to postpone pregnancy until they feel more secure in their job and personal life, and having the means to do this has significantly increased womens reproductive freedom. A womans fertility decreases naturally with age, however, the advances in fertility treatments mean its increasingly common for older women to become pregnant. Despite this, older mothers are at a much greater risk of complications during pregnancy, prompting the discussion of whether those who otherwise would not be able to conceive and safely carry a baby should, just because it is scientifically viable.

Conversely, reproductive rights defined by the World Health Organisation (WHO) state that everyone has the right to decide freely and responsibly the number, spacing and timing of their children and to have the information and means to do so. For most cases, there is a 10- year limit on freezing embryos, leaving people with a difficult decision once this time is up: destroying their embryos or beginning fertility treatment.

For some, 10 years later is still too soon to have a child. If we know embryos can survive for at least 27 years, why is this arbitrary limit still imposed? Does it really increase womens reproductive freedom as much as we think? Despite this, fertility Science & Technology treatments are life-changing, and the law rightly allows infertile couples and individuals the chance of having a family with their own or donated embryos. These treatments also provide the chance for same-sex couples to have children through means other than adopting, by using donated embryos or donated eggs/sperm. In December 2020, a 61-year-old gave birth to her own granddaughter by acting as a surrogate for her son and his husband.

A 61-year-old gave birth to her own granddaughter by acting as surrogate

The scientific advancements made during the last 40 years regarding fertility treatments have given many parents the chance of having a child. The record-breaking case of Molly Gibson has highlighted the prevalence and importance of these treatments being a possibility in todays society, meaning embryo adoption could become much more popular.

Image: Amber Conway

Excerpt from:
Embryo freezing is revolutionary for those who can't conceive - Palatinate

Mange in Yellowstone wolves reveals insights into human scabies and conservation biology – Princeton University

Before wolves were reintroduced to Yellowstone National Park in the mid-1990s, they were vaccinated for common diseases and treated for any parasite infections they already carried. As a result, the first few generations of wolves were relatively disease-free, but over the years, various diseases have found their way into the population.

Both of these Yellowstone wolves display the hair loss and skin lesions associated with mange. By analyzing 25 years of wolf observations and geneticsamples from 408 Yellowstone wolves, a Princeton-led research team found that genetics playa role in the severity of the mite-borne disease.Theyfound support for the "monoculture theory":wolves with severe mange, like the one on the left, tendto have less genetic variation than wolves with mild symptoms, as seen on the right.

Photos by Rebecca Raymond/National Park Service and Dan Stahler/National Park Service

Sarcoptic mange, caused by the microscopic mite Sarcoptes scabiei, first crawled its way into the reintroduced Yellowstone wolves in 2007. Mange is characterized by itchy skin lesions and hair loss, but there is huge variation between individuals in terms of how sick wolves actually become some experience mild mange symptoms and are able to clear the mites within a few months, while others experience massive hair loss, emaciation andsecondary bacterial infections, and eventually die of the disease. Mange isnt exclusively a disease of wolves, either. Sarcoptic mange mites infect more than 100 different mammalian species, including humans (where the disease is better known as scabies), and similar inter-individual variation in disease severity occurs in all of these host species.

Little is known about what causes thevariation in manginess, but a team of researchers, led by then-Princeton graduate student Alexandra DeCandia, sought to uncover this mystery. Their study, published in Evolutionary Applications, brings together schools of thought from molecular biology, disease ecology and conservation biology.

Genetics provide us with a really powerful tool for understanding wildlife health and conserving at-risk species, said DeCandia, who completed her Ph.D. in 2020 and is now a postdoctoral researcher at the Smithsonian Conservation Biology Institute. We can learn more about the causes of disease, the short- and long-term effects on individual animals and populations, and how best to respond as wildlife biologists and managers. For widespread diseases like mange, we can even gain insights into common processes that affect other host species including our own for a larger-scale One Health perspective that ultimately improves both human and wildlife health.

Though the researchers focused on wolves, the genetic pathways they uncovered will help pave the way for research into human scabies, which infects some 200 million people.

The premise of their research is based on a phenomenon known in agriculture as the monoculture effect, which predicts that the ability of individuals and populations to combat disease is related to genetic diversity. Individuals with higher genetic diversity are more resistant to disease, or more likely to experience mild disease, because they have more genetic tools with which to fight off diverse pathogens. Similarly, at the population scale, populations with higher genetic diversity may be less likely to experience disease outbreaks and more likely to survive outbreaks if they do occur.

Think of an agricultural monoculture. In a field of genetically identical bananas, for example, if a parasite is capable of infecting one banana tree, it has the tools needed to infect all of the banana trees. Of course, populations of wild animals are never monocultures, but they do vary in the amount of genetic variation they contain. And if the population in question originates from a small number of individuals, the amount of genetic variability available may be limited. Such is the case with the reintroduced wolves of Yellowstone National Park.

Leveraging over 25 years of wolf observational data and genetic samples from 408 individual wolves, the research team led by DeCandia and her adviser Bridgett vonHoldt, an associate professor in ecology and evolutionary biology at Princeton Universitylooked for patterns in overall genetic diversity associated with mange: Is the degree of individual-level genetic diversity associated with disease severity? Are specific genes involved? How did the introduction of mange impact genetic diversity at the population level? Using their years of observations, the researchers analyzed the genetic results in the context of broader wolf biology to see how genetic variation interacts with other factors behavioral, environmental and demographic to determine mange severity.

In individual wolves, the researchers found support for their hypothesis: wolves with severe mange tended to have less genetic variation than wolves with mild symptoms. Additionally, the study identified 410 genetic variants that are significantly associated with mange severity. These variants are known to play roles in inflammation, immunity and skin barrier integrity, and could potentially be molecular targets for mange or scabies treatment in other host species.

Professor Bridgett vonHoldt (center) isflanked by her graduate studentsin Yellowstone National Park in this photo from January 2019. From left: Dhriti Tandon, Elizabeth Heppenheimer, Alexandra DeCandia and Christopher Lawrence.

Photo by Axel Haenssen, Research Computing, Office of Information Technology

The researchers found that the best model of mange severity included not only genetic variation, but also took into account the age and breeding status of the wolf in question, and the season. Wolves tend to experience more severe mange in winter, when it is more difficult to thermoregulate; older wolves tended to have worse mange than younger wolves, although pups were not included in the study; and non-breeding wolves tend to be more mangy than breeders (though the direction of causation here is unclear it could be their manginess that prevents them from breeding).

At the population scale, overall genetic diversity has decreased in the Yellowstone wolves over the years.

Such changes in diversity are not unexpected, said vonHoldt, the senior author on the study. We have found that genetic diversity has been preserved well through mechanisms that shape pack and breeding pair formations. This recent opportunity to incorporate immunity and mange prevalence has really given us insights into the genetic dynamics shaped additionally by disease in a social carnivore.

Interestingly, gene variants that are associated with more severe mange have become less common in the population since mange emerged in 2007. This finding indicates that the disease is placing strong evolutionary selection pressure on the wolf population, weeding out those wolves most likely to succumb todeath from mange.

The findings are also significant for conservation biology, since maintaining healthy and genetically diverse individuals is one of the keys to conservation.

Conservation genetics has traditionally relied on a handful of genetic markers to inform captive breeding or wild population management, DeCandia said. For species of conservation concern, this research highlights the importance of examining both summary metrics of genome-wide variation and specific genes associated with disease.

In addition to DeCandia and vonHoldt, the other authors involved in the study were Edward Schrom, a 2020 graduate alumnus who is now a postdoctoral researcher at the National Institutes of Health; Ellen Brandell, a postdoctoral researcher at the University of Wisconsin-Madison; and Daniel Stahler, the lead wolf biologist at Yellowstone National Park.

Sarcoptic mange severity is associated with reduced genomic variation and evidence of selection in Yellowstone National Park wolves (Canis lupus), by Alexandra DeCandia, Edward C. Schrom, Ellen Brandell, Daniel R Rahler, and Bridgett vonHoldt, was published Sept. 10, 2020, in Evolutionary Applications (DOI: 10.1111/eva.13127). This work was supported by Princeton University's Department of Ecology and Evolutionary Biology and Center for Health and Wellbeing; the National Science Foundation (DEB0613730, DEB-1245373and DGE1656466); the Yellowstone Park Foundation (now Yellowstone Forever); and key donors, especially Annie and Bob Graham, Valerie Gates, and Frank and Kay Yeager.

Continued here:
Mange in Yellowstone wolves reveals insights into human scabies and conservation biology - Princeton University

ABC Sets Krista Vernoff Thursday As Rebel Joins Night & AMLT Moves; Greys Anatomy Return Delayed – Deadline

ABC has firmed up its midseason lineup, slotting premiere dates for new series Rebel, Home Economics and Pooch Perfect and setting new March return dates for its Thursday dramas.

Greys Anatomy, Station 19 and A Million Little Things, which originally were scheduled to come back from winter hiatus on March 4, will now be back March 11. The additional week is being provided as extra cushion amid unpredictable production interruptions and delays during the pandemic.

New drama Rebel, starring Katey Sagal and created by Krista Vernoff inspired by the life of Erin Brockovich today, will join ABCs Thursday lineup starting April 8. It will replace 10 PM anchor A Million Little Things, which will return to its former Wednesday 10 PM time slot, succeeding For Life after its 10-episode Season 2 concludes.

With Shondalands Station 19 at 8 PM and Greys Anatomy at 9 PM as well as Rebel at 10 PM, ABC will have an entire night from the same executive producer/showrunner, Vernoff, who runs all three series.

Starring Topher Grace, new comedy series Home Economicswill join ABCs Wednesday night comedy block, premiering April 7. It will succeed veteran American Housewife, which has a 12-episode Season 5 season order.

On the unscripted side, new eight-episode dog grooming competition Pooch Perfect, hosted by Rebel Wilson, will take over the Tuesday 8 PM hour, currently home of To Tell the Truth, on March 30.

ABC Is coming off a strong fall when it ranked as the most watched entertainment network for the first time In 20 years.

Here are the newly announced ABC midseason premiere dates followed by descriptions of the networks new shows:

THURSDAY, MARCH 11

8:00-9:00 p.m. Station 19 (new return date)

9:00-10:01 p.m. Greys Anatomy (new return date)

10:01-11:00 p.m. A Million Little Things (new return date)

TUESDAY, MARCH 30

8:00-9:00 p.m. Pooch Perfect (series premiere)

WEDNESDAY, APRIL 7

8:30-9:00 p.m. Home Economics (series premiere)

10:00-11:00 p.m. A Million Little Things (new day)

THURSDAY, APRIL 8

10:01-11:00 p.m. Rebel (series premiere)

POOCH PERFECT

Hosted by award-winning actress Rebel Wilson, Pooch Perfect is a dog grooming competition series. The eight-episode series will showcase 10 of the best dog groomers in the country, along with their assistants, competing in a series of paw-some themed challenges.

Each week on Pooch Perfect, teams will compete in the Immunity Puppertunity challenge, where one team will earn immunity from elimination. Then, in the Ultimutt Challenge showdown, the remaining teams will face off in an epic grooming transformation, which they will show off on the illustrious dogwalk. The trio of all-star celebrity judges Lisa Vanderpump, Jorge Bendersky and Dr. Callie Harris will be tasked with voting on the incredible creations and ultimately force one team back to the doghouse every week. It all leads up to the season finale where the top three teams compete for a giant cash prize and the coveted Pooch Perfect first place trophy.

Pooch Perfect is produced by Beyond Media Rights Limited. Elan Gale, Sonya Wilkes and Rebel Wilson serve as executive producers. Nicole Anthony, Mike Rosen, Carley Simpson and Matthew Silverberg serve as co-executive producers. ABCs Pooch Perfect is based off of the Australian format.

HOME ECONOMICS

Starring and executive produced by Topher Grace, Home Economics takes a look at the heartwarming yet super uncomfortable and sometimes frustrating relationship between three adult siblings: one in the 1%, one middle-class and one barely holding on. The comedy is inspired by the life of writer and executive producer Michael Colton.

The series stars Topher Grace as Tom, Caitlin McGee as Sarah, Jimmy Tatro as Connor, Karla Souza as Marina, and Sasheer Zamata as Denise. Also starring is Shiloh Bearman as Gretchen, Jordyn Curet as Shamiah, Chloe Jo Rountree as Camila and JeCobi Swain as Kelvin.

Home Economics was created by writers Michael Colton & John Aboud. They serve as executive producers alongside Topher Grace and Eric and Kim Tannenbaum of The Tannenbaum Company, whose Jason Wang will co-executive produce. The series is produced by Lionsgate and ABC Signature. ABC Signature, alongside 20th Television, is a part of Disney Television Studios.

REBEL

Inspired by the life of Erin Brockovich today, Annie Rebel Bello is a blue-collar legal advocate without a law degree. Shes a funny, messy, brilliant and fearless woman who cares desperately about the causes she fights for and the people she loves. When Rebel applies herself to a fight she believes in, she will win at almost any cost.

The series stars Katey Sagal as Annie Rebel Bello, John Corbett as Grady Bello, James Lesure as Benji, Lex Scott Davis as Cassidy, Tamala Jones as Lana, Ariela Barer as Ziggie, Kevin Zegers as Nate, Sam Palladio as Luke and Andy Garcia as Cruz.

Rebel is executive produced by Krista Vernoff and Alexandre Schmitt of Trip the Light, Erin Brockovich, John Davis and John Fox of Davis Entertainment, Andrew Stearn, Marc Webb and Adam Arkin. The series is produced by ABC Signature in association with Sony Pictures Television. ABC Signature, alongside 20th Television, is a part of Disney Television Studios.

Read more:
ABC Sets Krista Vernoff Thursday As Rebel Joins Night & AMLT Moves; Greys Anatomy Return Delayed - Deadline

Dissecting the Anatomy of Planetary Nebulae Using the Hubble Space Telescope – SciTechDaily

On the left is an image of the Jewel Bug Nebula (NGC 7027) captured by the Hubble Space Telescope in 2019 and released in 2020. Further analysis by researchers produced the RGB image on the right, which shows extinction due to dust, as inferred from the relative strength of two hydrogen emission lines, as red; emission from sulfur, relative to hydrogen, as green; and emission from iron as blue. Credit: STScI, Alyssa Pagan

Images of two iconic planetary nebulae taken by the Hubble Space Telescope are revealing new information about how they develop their dramatic features. Researchers from Rochester Institute of Technology and Green Bank Observatory presented new findings about the Butterfly Nebula (NGC 6302) and the Jewel Bug Nebula (NGC 7027) at the 237th meeting of the American Astronomical Society on Friday, January 15, 2021.

Hubbles Wide Field Camera 3 observed the nebulae in 2019 and early 2020 using its full, panchromatic capabilities, and the astronomers involved in the project have been using emission line images from near-ultraviolet to near-infrared light to learn more about their properties. The studies were first-of-their-kind panchromatic imaging surveys designed to understand the formation process and test models of binary-star-driven planetary nebula shaping.

Were dissecting them, saidJoel Kastner, a professor inRITs Chester F. Carlson Center for Imaging ScienceandSchool of Physics and Astronomy. Were able to see the effect of the dying central star in how its shedding and shredding its ejected material. Were now seeing where material that the central star has tossed away is being dominated by ionized gas, where its dominated by cooler dust, and even how the hot gas is being ionized, whether by the stars UV or by collisions caused by its present, fast winds.

On top is an image of the Butterfly Nebula (NGC 6302) captured by the Hubble Space Telescope in 2019 and released in 2020. Further analysis by researchers produced the RGB image on the bottom, which shows extinction due to dust, as inferred from the relative strength of two hydrogen emission lines, as red; emission from nitrogen, relative to hydrogen, as green; and emission from iron as blue. Credit: STScI, APOD/J. Schmidt; J. Kastner (RIT) et al.

Kastner said analysis of the new HST images of the Butterfly Nebula is confirming that the nebula was ejected only about 2,000 years agoan eyeblink by the standards of astronomy and established that the S-shaped iron emission that helps give it the wings of gas is even younger. Surprisingly, they found that while astronomers previously believed they had located the nebulas central star, that previously-identified star is actually not associated with the nebula and is instead much closer to Earth than the Butterfly Nebula. Kastner said he hopes that future studies with the James Webb Space Telescope could help locate the real dying star at the heart of the nebula.

The teams ongoing analysis of the Jewel Bug Nebula is built on a 25-year baseline of measurements dating back to early Hubble imaging. Paula Moraga Baez, an astrophysical sciences and technology Ph.D. student from DeKalb, Ill., called the nebula remarkable for its unusual juxtaposition of circularly symmetric, axisymmetric, and point-symmetric (bipolar) structures. Moraga noted, The nebula also retains large masses of molecular gas and dust despite harboring a hot central star and displaying high excitation states.

The RGB image on the right reveals the spatial separation of molecules CO+ (red) and HCO+ (blue), indicative of UV and X-ray processes, respectively. The much deeper optical image of [O III] (green) provides a juxtaposition of the ionized atomic structure and that of radio molecular observations. Credit: STScI, Alyssa Pagan; J. Bublitz (NRAO/GBO) et al.

Were very excited about these findings, said Bublitz. We had hoped to find structure that clearly showed CO+ and HCO+ spatially coincident or entirely in distinctive regions, which we did. This is the first map of NGC 7027, or any planetary nebula, in the molecule CO+, and only the second CO+ map of any astronomical source.

Meeting: 237th meeting of the American Astronomical Society

In addition to Kastner, Moraga, and Bublitz, the research team involved in the HST imaging work includes Rodolfo Montez Jr. 10 Ph.D. (astrophysical sciences and technology) from Harvard-Smithsonian CfA; Bruce Balick from University of Washington; as well as Adam Frank and Eric Blackman from University of Rochester. Bublitzs international team of collaborators on radio molecular line imaging of NGC 7027 includes Kastner, Montez Jr., and astrophysicists from Spain, France, and Brazil.

Continue reading here:
Dissecting the Anatomy of Planetary Nebulae Using the Hubble Space Telescope - SciTechDaily